{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:11:18Z","timestamp":1794964278557,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112\\u20132321-B-016-002"],"award-info":[{"award-number":["NSTC 112\\u20132321-B-016-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113\\u20132321-B-016-002"],"award-info":[{"award-number":["NSTC 113\\u20132321-B-016-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111\\u20132327-B-016-001"],"award-info":[{"award-number":["NSTC 111\\u20132327-B-016-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025478","name":"Taoyuan Armed Forces General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-C12\\u2013112048"],"award-info":[{"award-number":["MND-MAB-C12\\u2013112048"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-113160"],"award-info":[{"award-number":["MND-MAB-D-113160"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Ministry of National Defense Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-114188"],"award-info":[{"award-number":["MND-MAB-D-114188"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.vaccine.2025.127219","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T02:56:39Z","timestamp":1746586599000},"page":"127219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement"],"prefix":"10.1016","volume":"57","author":[{"given":"Shiu-Bii","family":"Lien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao-Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Chou","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui-Lung","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Len","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Chen","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.127219_bb0005","first-page":"9","article-title":"The 5\u2032 and 3\u2019 untranslated regions of the Flaviviral genome","author":"Ng","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.127219_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.02.002","article-title":"Structural perspectives of antibody-dependent enhancement of infection of dengue virus","volume":"36","author":"Morrone","year":"2019","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0015","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2019.197770","article-title":"Flavivirus infection-a review of immunopathogenesis, immunological response, and immunodiagnosis","volume":"274","author":"Chong","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2025.127219_bb0025","doi-asserted-by":"crossref","first-page":"16055","DOI":"10.1038\/nrdp.2016.55","article-title":"Dengue infection","volume":"2","author":"Guzman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.vaccine.2025.127219_bb0030","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: an integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127219_bb0035","first-page":"12","article-title":"Mapping global variation in dengue transmission intensity","author":"Cattarino","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2025.127219_bb0040","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fcimb.2017.00317","article-title":"Global epidemiology of dengue outbreaks in 1990-2015: a systematic review and Meta-analysis","volume":"7","author":"Guo","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1128\/CMR.00072-15","article-title":"Zika Virus","volume":"29","author":"Musso","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2025.127219_bb0050","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJMra1808246","article-title":"Zika virus infection \u2014 after the pandemic","volume":"381","author":"Musso","year":"2019","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2025.127219_bb0055","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1038\/s41564-019-0476-8","article-title":"The current and future global distribution and population at risk of dengue","volume":"4","author":"Messina","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1042\/ETLS20180123","article-title":"Climate change and the rising infectiousness of dengue","volume":"3","author":"Rockl\u00f6v","year":"2019","journal-title":"Emerging Topics in Life Sciences"},{"key":"10.1016\/j.vaccine.2025.127219_bb0065","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-018-06006-6","article-title":"Refined efficacy estimates of the Sanofi Pasteur dengue vaccine CYD-TDV using machine learning","volume":"9","author":"Dorigatti","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.127219_bb0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-med-091014-090848","article-title":"Vaccination against dengue: challenges and current developments","volume":"67","author":"Guy","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2025.127219_bb0075","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1056\/NEJMc1514451","article-title":"Dengue vaccine in regions of endemic disease","volume":"374","author":"Saville","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.127219_bb0080","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3934\/mbe.2019056","article-title":"Optimal dengue vaccination strategies of seropositive individuals","volume":"16","author":"Shim","year":"2019","journal-title":"Math Biosci Eng"},{"key":"10.1016\/j.vaccine.2025.127219_bb0085","doi-asserted-by":"crossref","first-page":"1202055","DOI":"10.3389\/fimmu.2023.1202055","article-title":"Identification of prior dengue-na\u00efve Dengvaxia recipients with an increased risk for symptomatic dengue during fever surveillance in the Philippines","volume":"14","author":"Dai","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009258","article-title":"Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)","volume":"15","author":"White","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127219_bb0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3389\/fimmu.2020.01252","article-title":"Anti-dengue vaccines: from development to clinical trials","volume":"11","author":"Pinheiro-Michelsen","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1473-3099(17)30632-1","article-title":"Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study","volume":"18","author":"S\u00e1ez-Llorens","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127219_bb0105","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1016\/j.vaccine.2018.05.028","article-title":"A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127219_bb0110","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1128\/JVI.05237-11","article-title":"A fusion-loop antibody enhances the infectious properties of immature flavivirus particles","volume":"85","author":"Rodenhuis-Zybert","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0115","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41541-016-0003-3","article-title":"A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus","volume":"2","author":"Xu","year":"2017","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.vaccine.2025.127219_bb0120","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007716","article-title":"Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127219_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00873-13","article-title":"The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein","volume":"4","author":"Smith","year":"2013","journal-title":"mBio"},{"key":"10.1016\/j.vaccine.2025.127219_bb0135","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-023-00938-y","article-title":"Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement","volume":"30","author":"Yen","year":"2023","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2025.127219_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002451","article-title":"Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases","volume":"7","author":"Lai","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2025.127219_bb0145","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3389\/fmicb.2017.01372","article-title":"Complexity of human antibody response to dengue virus: implication for vaccine development","volume":"8","author":"Tsai","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0150","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4021","article-title":"Generation and characterization of cross neutralizing human monoclonal antibody against 4 serotypes of dengue virus without enhancing activity","volume":"5","author":"Injampa","year":"2017","journal-title":"PeerJ"},{"key":"10.1016\/j.vaccine.2025.127219_bb0155","doi-asserted-by":"crossref","first-page":"1200195","DOI":"10.3389\/fimmu.2023.1200195","article-title":"Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement","volume":"14","author":"Sarker","year":"2023","journal-title":"Front Immunol"},{"issue":"1114\u201325","key":"10.1016\/j.vaccine.2025.127219_bb0160","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2025.127219_bb0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-9-115","article-title":"Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement","volume":"9","author":"Hughes","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2025.127219_bb0170","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0175","doi-asserted-by":"crossref","first-page":"12562","DOI":"10.1128\/JVI.00871-13","article-title":"High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection","volume":"87","author":"Tsai","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0180","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1128\/JVI.72.12.9729-9737.1998","article-title":"Study of dengue virus infection in SCID mice engrafted with human K562 cells","volume":"72","author":"Lin","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0185","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.bbrc.2012.06.057","article-title":"Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection","volume":"423","author":"Setthapramote","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2025.127219_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/e08f911a-15ec-46d0-bede-83fdf3af1801","article-title":"Therapeutic efficacy of antibodies lacking Fcgamma receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]","volume":"9","author":"Williams","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2025.127219_bb0195","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a Flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2025.127219_bb0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016059","article-title":"A broadly flavivirus cross-neutralizing monoclonal antibody that recognizes a novel epitope within the fusion loop of E protein","volume":"6","author":"Deng","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.vaccine.2025.127219_bb0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2025.127219_bb0210","first-page":"8","article-title":"A recombinant Zika virus envelope protein with mutations in the conserved fusion loop leads to reduced antibody cross-reactivity upon vaccination","author":"Berneck","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.127219_bb0215","doi-asserted-by":"crossref","first-page":"1279147","DOI":"10.3389\/fcimb.2023.1279147","article-title":"Immunization with different recombinant West Nile virus envelope proteins induces varying levels of serological cross-reactivity and protection from infection","volume":"13","author":"Weiss","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2019.09.007","article-title":"A clinical and epidemiological survey of the largest dengue outbreak in southern Taiwan in 2015","volume":"88","author":"Wang","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2025.127219_bb0225","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2025.127219_bb0230","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ymthe.2022.01.013","article-title":"Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on indo-African sequences","volume":"30","author":"Sankaradoss","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.127219_bb0235","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1016\/j.vaccine.2010.07.073","article-title":"Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses","volume":"28","author":"Brandler","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.127219_bb0240","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2003.69.48","article-title":"Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine","volume":"69","author":"Edelman","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2025.127219_bb0245","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41590-021-00966-6","article-title":"Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch","volume":"22","author":"Dai","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2025.127219_bb0250","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500516X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2500516X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T17:41:49Z","timestamp":1762278109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2500516X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":50,"alternative-id":["S0264410X2500516X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127219","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.127219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"127219"}}